{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-135822","form_type":"8-K","ticker":"AKTX","cik":"0001541157","company_name":"Akari Therapeutics Plc","filed_at":"2024-12-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.748526+00:00","generated_at":"2026-05-29T04:04:17.053608+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Akari Therapeutics: Interim CFO Wendy DiCicco departs; CEO Samir Patel assumes interim PFO/PAO roles","bullets":["Wendy DiCicco's consulting agreement terminated on December 6, 2024, ending her role as Interim CFO, PFO, and PAO.","Samir Patel, Interim CEO, appointed as Interim Principal Financial Officer and Principal Accounting Officer effective December 12, 2024.","Board initiated search for a new Chief Financial Officer.","Separation terms for DiCicco are being finalized and will be disclosed in a subsequent filing."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-135822","json":"https://secwatch.observer/filing/0000950170-24-135822.json","markdown":"https://secwatch.observer/filing/0000950170-24-135822.md","text":"https://secwatch.observer/filing/0000950170-24-135822.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1541157/000095017024135822/0000950170-24-135822-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1541157/000095017024135822/aktx-20241206.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-29T04:04:17.053608+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}